IgG N-糖基与CKD不良结局的关联
在德国CKD队列4782例患者中,发现IgG N-糖基化模式与基线肾功能、6.5年死亡及肾衰竭相关;无半乳糖IgG与更低eGFR和更高死亡风险相关,双半乳糖和唾液酸化IgG则与更高eGFR和更低死亡风险相关;孟德尔随机化提示eGFR与特定N-糖基特征存在双向因果关联。
要点
- 高无半乳糖IgG与eGFR降低4%/SD及死亡风险增加39%相关。
- 高双半乳糖和唾液酸化IgG与eGFR升高5%及死亡风险降低相关。
- IgG N-糖基或可作为CKD免疫生物标志物,需进一步验证。
核心结论
- IgG N-糖基模式反映炎症衰老,并与CKD肾功能、死亡及肾衰竭相关。
- IgG N-糖基是CKD潜在的免疫生物标志物,因果相关性需进一步验证。
研究设计与样本
- 德国CKD(GCKD)研究队列,纳入4782例eGFR 30-60 ml/min/1.73 m2或明显白蛋白尿的参与者。
- 采用超高效液相色谱测量IgG N-糖基峰,线性回归和Cox回归分析关联,双向孟德尔随机化探索因果。
主要发现
- 较高无半乳糖IgG与较低eGFR(-4%/SD;97.9% CI:-6%至-3%)和较高死亡率(HR 1.39;97.9% CI:1.19-1.62)相关。
- 较高双半乳糖和唾液酸化IgG与较高eGFR(+5%)和较低死亡率(HR分别为0.68和0.80)相关。
- 与UACR和肾衰竭的关联因年龄、性别和自身免疫状态而异;核心岩藻糖和平分型GlcNAc关联较弱,主要与UACR相关。
- 孟德尔随机化提示eGFR与特定N-糖基特征之间存在双向因果关系。
关键数值与推荐
- 队列平均年龄60岁,女性40%,中位eGFR 46 ml/min/1.73 m2,自身免疫性肾病占22%。
- 随访6.5年,评估基线肾功能、死亡和肾衰竭结局。
临床怎么用
- IgG N-糖基可能作为CKD风险评估的免疫生物标志物,但当前证据尚不足以指导临床决策。
- 需进一步验证因果相关性后再考虑临床应用。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: IgG N-glycosylation modulates inflammation and may influence chronic kidney disease (CKD). We investigated associations between IgG N-glycan patterns, kidney function, mortality, and kidney failure (KF) within the German CKD (GCKD) study. METHODS: IgG N-glycan peaks were measured using ultrahigh-performance liquid chromatography in 4782 GCKD participants (estimated glomerular filtration rate [eGFR]: 30-60 ml/min per 1.73 m2 or overt albuminuria). We assessed associations with baseline kidney function, 6.5-year mortality, and KF using linear and Cox regression. We used bidirectional Mendelian randomization (MR) to explore causal relationships. RESULTS: The cohort comprised 4782 participants (mean age: 60 years, 40% women) with a median eGFR of 46 ml/min per 1.73 m2, and autoimmune kidney disease in 22%. Higher agalactosylated IgG was associated with lower eGFR (-4%/SD; 97.9% confidence interval [CI]: -6% to -3%) and higher mortality (hazard ratio [HR]: 1.39; 97.9% CI: 1.19-1.62). Conversely, higher digalactosylated and sialylated IgG were associated with higher eGFR (+5%) and lower mortality (HR: 0.68 and 0.80, respectively). Associations with urinary albumin-to-creatine ratio [UACR] and KF varied by age, sex, and autoimmune status. Core fucosylation and bisecting N-acetylglucosamine (GlcNAc) showed weaker associations, primarily with UACR. MR suggested bidirectional causal relationships between eGFR and specific N-glycan traits. CONCLUSION: IgG N-glycan patterns reflect inflammatory aging and associate with kidney function, mortality, and KF in CKD. These findings identify IgG N-glycans as potential immunologic biomarkers for CKD. Further validation is required to confirm causal relevance.
引用
- Butz E, Bach MIJ, Kotsis F, et al. Association of IgG N-Glycans With Adverse Outcomes in CKD. Kidney Int Rep. 2026. PMID: 42394719. doi:10.1016/j.ekir.2026.106615
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。